Centessa Pharmaceuticals, founded from the merger of 10 biotech companies, is based on an asset-centric model, primarily ...

Rubric Capital Management LP boosted its position ... The company’s lead product candidates include zanidatamab, a human ...

Gain Therapeutics' GT-02287 shows promise in treating Parkinson's disease, with positive results and potential for market ...

Director Ecor1 Capital, Llc purchased 11,958 shares of the firm’s stock in a transaction dated Tuesday, December 24th. The ...

Stemming from the slogan “Qatar deserves the best from its citizens”, repeatedly emphasised by the country’s wise leadership, ...

About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug ...

Detailed price information for Bio-Path Holdings (BPTH-Q) from The Globe and Mail including charting and trades.

The State of Qatar continues its journey on the path of development and construction, moving with firm and steady steps ...

The new model shows open-source closing in on closed-source models, suggesting reduced chances of one big AI player ruling the game.

From Prestige Estates to HSCL, Bajaj Broking has picked its top five stocks to buy in the new year for a 12 month investment.

Sunny Jaiswal is a distinguished Oracle HCM leader with extensive experience in cloud implementations and solution ...

ORLANDO, Fla., Dec. 31, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders highlighting the ...